207 related articles for article (PubMed ID: 21732778)
1. Aberrant protein expression and promoter methylation of p16 gene are correlated with malignant transformation of salivary pleomorphic adenoma.
Hu YH; Zhang CY; Tian Z; Wang LZ; Li J
Arch Pathol Lab Med; 2011 Jul; 135(7):882-9. PubMed ID: 21732778
[TBL] [Abstract][Full Text] [Related]
2. Quantitative promoter methylation differentiates carcinoma ex pleomorphic adenoma from pleomorphic salivary adenoma.
Schache AG; Hall G; Woolgar JA; Nikolaidis G; Triantafyllou A; Lowe D; Risk JM; Shaw RJ; Liloglou T
Br J Cancer; 2010 Dec; 103(12):1846-51. PubMed ID: 21063414
[TBL] [Abstract][Full Text] [Related]
3. Assessment of inverse correlation of p16 and pRb expression in carcinoma ex pleomorphic adenoma.
Tarakji B; Alenzi F; Al-Khuraif AA
Pol J Pathol; 2013 Jun; 64(2):144-8. PubMed ID: 23900873
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions.
Di Palma S
Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S68-76. PubMed ID: 23821206
[TBL] [Abstract][Full Text] [Related]
5. PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases.
Bahrami A; Dalton JD; Shivakumar B; Krane JF
Head Neck Pathol; 2012 Sep; 6(3):328-35. PubMed ID: 22485045
[TBL] [Abstract][Full Text] [Related]
6. High frequency of p16 and p14 promoter hypermethylation and marked telomere instability in salivary gland tumors.
Nikolic N; Anicic B; Carkic J; Simonovic J; Toljic B; Tanic N; Tepavcevic Z; Vukadinovic M; Konstantinovic VS; Milasin J
Arch Oral Biol; 2015 Nov; 60(11):1662-6. PubMed ID: 26351750
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.
de Souza AA; Altemani A; Passador-Santos F; Turssi CP; de Araujo NS; de Araújo VC; Soares AB
Virchows Arch; 2015 Sep; 467(3):295-301. PubMed ID: 26155914
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 and p16 expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma of the parotid gland.
Patel RS; Rose B; Bawdon H; Hong A; Lee CS; Fredericks S; Gao K; O'Brien CJ
Histopathology; 2007 Nov; 51(5):691-6. PubMed ID: 17927591
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of mammaglobin in salivary duct carcinomas de novo and salivary duct carcinoma ex pleomorphic adenoma.
Soares CD; de Lima Morais TM; Carlos R; Martins MD; de Almeida OP; Mariano FV; Altemani A
Hum Pathol; 2019 Oct; 92():59-66. PubMed ID: 31400353
[TBL] [Abstract][Full Text] [Related]
10. Expression of p16
Bartkowiak E; Piwowarczyk K; Bodnar M; Kosikowski P; Chou J; Woźniak A; Wierzbicka M
J Clin Pathol; 2022 Sep; 75(9):605-611. PubMed ID: 33941588
[TBL] [Abstract][Full Text] [Related]
11. Carcinoma ex pleomorphic adenoma: A diagnostic challenge on cytology.
Singh K; Agarwal C; Pujani M; Verma P; Chauhan V
Diagn Cytopathol; 2017 Jul; 45(7):651-654. PubMed ID: 28261993
[TBL] [Abstract][Full Text] [Related]
12. An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Hoch BL; Wu M; Lewis M; Gan L; Burstein DE
J Oral Pathol Med; 2008 Nov; 37(10):634-8. PubMed ID: 18673415
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.
Matsubayashi S; Yoshihara T
Eur Arch Otorhinolaryngol; 2007 Jul; 264(7):789-95. PubMed ID: 17310348
[TBL] [Abstract][Full Text] [Related]
14. Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Andreasen S; von Holstein SL; Homøe P; Heegaard S
Acta Ophthalmol; 2018 Nov; 96(7):e768-e771. PubMed ID: 29437290
[TBL] [Abstract][Full Text] [Related]
15. Peroxiredoxin I, platelet-derived growth factor A, and platelet-derived growth factor receptor alpha are overexpressed in carcinoma ex pleomorphic adenoma: association with malignant transformation.
Demasi AP; Furuse C; Soares AB; Altemani A; Araújo VC
Hum Pathol; 2009 Mar; 40(3):390-7. PubMed ID: 18992915
[TBL] [Abstract][Full Text] [Related]
16. Pleomorphic adenoma and carcinoma ex pleomorphic adenoma: immunohistochemical demonstration of the association between tenascin expression and malignancy.
Félix A; Rosa JC; Fonseca I; Cidadão A; Soares J
Histopathology; 2004 Aug; 45(2):187-92. PubMed ID: 15279638
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation may contribute to E‑cadherin repression in the human salivary carcinoma ex pleomorphic adenoma.
Xia L; Hu Y; Gu T; Wang L; Tian Z
Int J Oncol; 2018 Feb; 52(2):496-504. PubMed ID: 29207084
[TBL] [Abstract][Full Text] [Related]
18. Lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma: genomic profiles, gene fusions, and clinical characteristics.
von Holstein SL; Fehr A; Persson M; Nickelsen M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
Ophthalmology; 2014 May; 121(5):1125-33. PubMed ID: 24468654
[TBL] [Abstract][Full Text] [Related]
19. The interleukin-6/Janus kinase/STAT3 pathway in pleomorphic adenoma and carcinoma ex pleomorphic adenoma of the lacrimal gland.
Andreasen S; Heegaard S; Grauslund M; Homøe P
Acta Ophthalmol; 2016 Dec; 94(8):798-804. PubMed ID: 27286739
[TBL] [Abstract][Full Text] [Related]
20. Increased mucin 1 expression in recurrence and malignant transformation of salivary gland pleomorphic adenoma.
Soares AB; Demasi AP; Altemani A; de Araújo VC
Histopathology; 2011 Feb; 58(3):377-82. PubMed ID: 21323961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]